Date of dispatch of this notice: 13/12/2018
Expire date: 22/02/2019
External Reference: 2018-233389
TED Reference: 2018/S 243-555399
Contract notice
Information
Published
Contract notice
Contract notice
Directive 2014/24/EU
Section I: Contracting authority
I.1)
Name and addresses
Health Service Executive (HSE)
N/A
Head Office
Naas
Millennium Park
IE
Contact person:
Joe Heavey
Telephone:
+353 061482690
E-mail:
joe.heavey@hse.ie
Fax:
+353 061464230
Internet address(es):
Main address:
http://www.hse.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/461
I.2)
Joint procurement
The contract is awarded by a central purchasing body
I.3)
Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=139496&B=ETENDERS_SIMPLEAdditional information can be obtained from
the abovementioned address:
Tenders or requests to participate must be submitted
electronically via:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=139496&B=ETENDERS_SIMPLE
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Health
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
Improving the Care of Patients - Gestational Diabetes & Diabetic Foot
Reference number:
SBIR Challenge - HSE
II.1.2)
Main CPV code
73300000
-
Design and execution of research and development
II.1.3)
Type of contract
Services
II.1.4)
Short description
The Challenge Background
Diabetes is a serious global public health issue which has been described as the most challenging health problem in the 21st century. Between 1998 and 2015, there was a significant increase in the prevalence of doctor diagnosed diabetes among adults in Ireland (increasing from 2.2 % in 1998 to 5.2 % in 2015). The prevalence of undiagnosed diabetes in Ireland ranges from 0.9 – 2.8% of the population. People with diabetes are at serious risk of developing microvascular complications which can result in damage to feet, resulting in loss of sensation, damage to the back of the eye which can lead to blindness and damage to kidneys which can result in kidney failure.
This small business Innovation Research (SBIR) competition specifically targets two key unmet needs:
1) Reducing the risk of women developing diabetes following gestational diabetes
2) Screening for diabetic foot disease in all patients with diabetes
Diabetes is a serious global public health issue which has been described as the most challenging health problem in the 21st century. Between 1998 and 2015, there was a significant increase in the prevalence of doctor diagnosed diabetes among adults in Ireland (increasing from 2.2 % in 1998 to 5.2 % in 2015). The prevalence of undiagnosed diabetes in Ireland ranges from 0.9 – 2.8% of the population. People with diabetes are at serious risk of developing microvascular complications which can result in damage to feet, resulting in loss of sensation, damage to the back of the eye which can lead to blindness and damage to kidneys which can result in kidney failure.
This small business Innovation Research (SBIR) competition specifically targets two key unmet needs:
1) Reducing the risk of women developing diabetes following gestational diabetes
2) Screening for diabetic foot disease in all patients with diabetes
II.1.5)
Estimated total value
Value excluding VAT: 200000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
yes
Tenders may be submitted for
all lots
The contracting authority reserves the right to award contracts combining the following lots or groups of lots:
Lots 1 & 2
II.2)
Description
II.2.1)
Title
Lot No:
1
II.2.2)
Additional CPV code(s)
73110000
-
Research services
73210000
-
Research consultancy services
73300000
-
Design and execution of research and development
II.2.4)
Description of the procurement
1) Reducing the risk of women developing diabetes following gestational diabetes
II.2.5)
Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)
Estimated value
Value excluding VAT: 200000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
3
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
yes
Description of options:
Enterprise Ireland and the HSE are seeking innovative solutions to the challenges listed so therefore will be open to options that offer viable solutions.
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2)
Description
II.2.1)
Title
Lot No:
3
II.2.2)
Additional CPV code(s)
73110000
-
Research services
73210000
-
Research consultancy services
73300000
-
Design and execution of research and development
II.2.4)
Description of the procurement
Screening for diabetic foot disease in all patients with diabetes
II.2.5)
Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)
Estimated value
Value excluding VAT: 200000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
3
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
Section III: Legal, economic, financial and technical information
III.1)
Conditions for participation
III.1.2)
Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3)
Technical and professional ability
Selection criteria as stated in the procurement documents
III.2)
Conditions related to the contract
III.2.2)
Contract performance conditions
As stated in the procurement documents
III.2.3)
Information about staff responsible for the performance of the contract
Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract
Section IV: Procedure
IV.1)
Description
IV.1.1)
Type of procedure
Open procedure
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement
: yes
IV.2)
Administrative information
IV.2.2)
Time limit for receipt of tenders or requests to participate
Date:
22/02/2019
Local time:
18:00
IV.2.4)
Languages in which tenders or requests to participate may be submitted
English
IV.2.6)
Minimum time frame during which the tenderer must maintain the tender
Duration in months
: 6
(from the date stated for receipt of tender)
IV.2.7)
Conditions for opening of tenders
Date:
22/02/2019
Local time:
18:00
Place:
The electronic postbox will be opened by at two designated HSE staff after the official closing date for the competition.
Section VI: Complementary information
VI.1)
Information about recurrence
This is a recurrent procurement:
no
VI.2)
Information about electronic workflows
Electronic payment will be used
VI.4)
Procedures for review
VI.4.1)
Review body
The High Court
Four Courts
Dublin
7
IE